Answers are grounded in this paper and cite their sources.
Neurodegenerative diseases are increasingly recognized as disorders of chronic cellular stress in which mitochondrial oxidative stress plays a central pathogenic role. Excessive generation of reactive oxygen species (ROS) and impaired antioxidant defenses disrupt neuronal redox homeostasis, leading to bioenergetic failure, calcium dysregulation, proteostasis imbalance, mitochondrial dynamic defects, and neuroinflammatory responses. This review examines the major sources and mechanisms of mitochondrial ROS production and highlights the interplay between mitochondrial oxidative stress and other cellular stress pathways, including endoplasmic reticulum stress, lipid peroxidation, and neuroinflammation. We discuss the contribution of mitochondrial dysfunction to the pathogenesis of major neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. Established and emerging biomarkers of mitochondrial oxidative damage, such as 8-hydroxy-2′-deoxyguanosine, protein carbonyls, F2-isoprostanes, and cell-free mitochondrial DNA, are critically evaluated alongside their translational limitations. Furthermore, we integrate recent advances in mitochondrial quality control, mitophagy, NAD⁺ restoration, and mitochondrial stress resilience as promising therapeutic approaches. Collectively, current evidence supports mitochondrial oxidative stress as a unifying upstream driver linking protein aggregation, neuroinflammation, bioenergetic dysfunction, and progressive neuronal loss. Targeting mitochondrial redox homeostasis and quality-control pathways may therefore provide effective disease-modifying strategies for neurodegenerative disorders.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: